Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings. [electronic resource]
Producer: 20190930Description: 556-562 p. digitalISSN:- 1995-9133
- Adult
- Antiviral Agents -- economics
- Coinfection -- drug therapy
- Cost-Benefit Analysis
- Drug Therapy, Combination -- economics
- Female
- Genotype
- HIV Infections -- complications
- Health Care Costs
- Hepatitis C, Chronic -- complications
- Humans
- Male
- Middle Aged
- Prisons
- Retrospective Studies
- Ribavirin -- economics
- Taiwan
- Viral Load
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.